Pfizer CEO defends Astra deal, says committed to UK science

[Reuters – UK Focus] – U.S. drug company Pfizer (TLO: PF-U.TI – news) fought back on Saturday (Shenzhen: 002291.SZ – news) against criticism that its planned takeover of drugmaker AstraZeneca (NYSE: AZN – news) would damage Britain’s science base by sayi more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard

See who Astrazeneca is hiring next, click here to view